Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01599988
Other study ID # APC032
Secondary ID
Status Completed
Phase Phase 2/Phase 3
First received March 13, 2012
Last updated January 15, 2013
Start date October 2011
Est. completion date April 2012

Study information

Verified date January 2013
Source University College Cork
Contact n/a
Is FDA regulated No
Health authority Ireland: Medical Ethics Research Committee
Study type Interventional

Clinical Trial Summary

The Clinical Research Ethics Committee, Cork comprises of faculty representatives, external representatives, legal representatives and appropriate individuals and ex-officio administrative members with needed expertise. Ethics Committee members, including the Chair, are appointed by the Head of College, University College Cork, Medical School.

The Ethics Committee meets once a month.


Recruitment information / eligibility

Status Completed
Enrollment 24
Est. completion date April 2012
Est. primary completion date March 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 65 Years to 75 Years
Eligibility Inclusion Criteria:

To be considered eligible for enrolment into the study, subjects must;

1. Be able to give written informed consent.

2. Be between 65 and 75 years of age.

3. Be in generally good health as determined by the investigator.

4. Have no evidence of gastrointestinal disease or of a functional gastrointestinal disorder as determined by the Bowel Disease Questionnaire.

5. Have a stable body weight over the past 3-months.

6. Have a Body Mass Index (BMI) greater than 22, for males and 20 for females and less than 30.

7. Have a satisfactory nutritional status.

Exclusion Criteria:

Subjects will be excluded from the study if they meet any of the below criteria;

1. Are less than 65 and greater than 75 years of age.

2. Have evidence of gastrointestinal disease or other functional gastrointestinal disorder as determined by the Bowel Disease Questionnaire.

3. Have a significant acute or chronic coexisting illness (cardiovascular, gastrointestinal, endocrinological, immunological, metabolic or any condition which contraindicates, in the investigators judgement, entry to the study).

4. Having a condition or taking a medication that the investigator believes would interfere with the objectives of the study, pose a safety risk or confound the interpretation of the study results; to include anti-inflammatory drugs, corticosteroids, laxatives, enemas, antibiotics (within 1 month), anti-coagulants, and over-the counter non-steroidal analgesics. Subjects should have a wash-out period of two-weeks.

5. Be a smoker.

6. Consume more than the recommended alcohol guidelines i.e. 3-4 alcohol units a day for a man and for a woman 2-3 units a day.

7. Suffer from psychiatric disease

8. Prior gastrointestinal surgery (apart from appendicectomy and hernia repair) or recent unexplained bleeding.

9. Have dietary habits (slimming or vegetarian diet) which could interfere with the assessment of the study product.

10. Individuals who, in the opinion of the investigator, are considered to be poor attendees or unlikely for any reason to be able to comply with the trial.

11. Subjects may not be receiving treatment involving experimental drugs.

12. If the subject has been in a recent experimental trial, these must have been completed not less than 30 days prior to this study.

13. Have a malignant disease or any concomitant end-stage organ disease

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Caseinate
The test meal is a vanilla flavoured enteral drink, containing 1.5kcal/ml, 21% CHO, 6% protein and 5% fat. The 6% protein in this test meal is Caseinate
Milk Protein Isolate
The test meal is a vanilla flavoured enteral drink, containing 1.5kcal/ml, 21% CHO, 6% protein and 5% fat. The 6% protein in this test meal is Milk Protein Isolate.

Locations

Country Name City State
Ireland University College Cork Cork

Sponsors (1)

Lead Sponsor Collaborator
University College Cork

Country where clinical trial is conducted

Ireland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Protein utilization Up to 8 hours No
Secondary Blood glucose concentrations Up to 8 hours No
Secondary Plasma insulin levels Up to 8 hours No
Secondary Serum triglycerides Up to 8 hours No